首页> 美国卫生研究院文献>Oncology Research >T-box Transcription Factor Tbx3 Contributes to Human Hepatocellular Carcinoma Cell Migration and Invasion by Repressing E-Cadherin Expression
【2h】

T-box Transcription Factor Tbx3 Contributes to Human Hepatocellular Carcinoma Cell Migration and Invasion by Repressing E-Cadherin Expression

机译:T型盒转录因子TBX3通过抑制E-Cadherin表达有助于人类肝细胞癌细胞迁移和侵袭

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Tbx3, a member of the T-box family of transcription factors, contributes directly to tumor formation, migration, and invasion. However, the role of Tbx3 in the metastasis of HCC remains unclear. In the present study, Tbx3 expression was detected in HCC tissues and cells by Western blot, and Tbx3 expression was regulated by use of siRNAs or lentivirus-mediated vectors. Here we found that Tbx3 protein expression increased in HCC tissues and cell lines. Tbx3 expression was positively associated with multiple tumor nodes, venous infiltration, and advanced TNM tumor stage. Survival analysis demonstrated that Tbx3 expression was an independent prognostic factor for HCC patients. In vitro assays further validated that Tbx3 indeed prompted HCC cell migration and invasion. In addition, Tbx3 expression was negatively related with E-cadherin expression in HCC tissues. Mechanically, Tbx3 inhibited the expression of E-cadherin, and then facilitated epithelial–mesenchymal transition (EMT) of HCC cells. Furthermore, the effect of Tbx3 knockdown on HCC cells was attenuated by E-cadherin knockdown. In conclusion, Tbx3 may be a novel prognostic factor, and it contributes to HCC cell migration, invasion, and EMT by repressing E-cadherin expression. Thus, Tbx3 may be recommended as a therapeutic target for HCC patients.
机译:TBX3是T-Box系列转录因子的成员,有助于肿瘤形成,迁移和入侵。然而,TBX3在HCC转移中的作用仍不清楚。在本研究中,通过Western印迹在HCC组织和细胞中检测TBX3表达,并通过使用siRNA或慢病毒介导的载体调节TBX3表达。在这里,我们发现HCC组织和细胞系中TBX3蛋白表达增加。 TBX3表达与多种肿瘤节点,静脉浸润和晚期TNM肿瘤阶段呈正相关。存活分析表明TBX3表达是HCC患者的独立预后因素。体外测定进一步验证了TBX3确实促使HCC细胞迁移和侵袭。此外,TBX3表达与HCC组织中的E-Cadherin表达呈负相关。机械地,TBX3抑制E-Cadherin的表达,然后促进HCC细胞的上皮 - 间充质转换(EMT)。此外,通过E-cadherin敲低,TBX3敲低对HCC细胞的影响。总之,TBX3可以是一种新的预后因子,并且通过抑制E-Cadherin表达,它有助于HCC细胞迁移,侵袭和EMT。因此,可以推荐TBX3作为HCC患者的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号